Lightstone Ventures
5 rounds tracked since 5 June 2025.
- Rounds
- 5
- Led
- 1
- Capital in these rounds
- $498M
Sectors
Countries
Rounds
- PsiTheraDevelops oral medicines for immune and inflammatory diseases $25M10 Nov
- Crystalys TherapeuticsDeveloper of dotinurad, an oral URAT1 blocker for gout $205MSeries A · 30 Sept
- ProVerumMaker of the ProVee System, a minimally invasive stent for enlarged prostate $80MSeries B · 2 Sept
- Apreo HealthDeveloping the BREATHE airway scaffold implant for severe emphysema $130MSeries B · 7 Aug
- Allay TherapeuticsLeadUltra-sustained non-opioid analgesics for post-surgical pain $57.5MSeries D · 5 Jun
No round matches these filters.